Lisa Lombardi

TL;DR: Staphylococcus aureus-specific bacteriophage Sb-1 can degrade the MRSA polysaccharide matrix and target persister cells and is therefore suitable for treatment of biofilm-associated infections.

TL;DR: In this article, the authors comprehensively discuss the current clinical challenges caused by A. fumigatus and provide insights on how to address them and provide a continuous quest for novel antifungal drugs.

TL;DR: This review focuses on the hepcidins, which are peptides produced by the human liver with a known role in iron homeostasis, as well by numerous other organisms, and their potential as antibacterial and antifungal agents, and critically assesses technical obstacles preventing their therapeutic application.

TL;DR: This review discusses how the further evolution of CRISPR technology will allow mycologists to tackle the multifaceted issue of fungal pathogenesis and highlights the most promising future perspectives, including gene drives, programmable base editors, and nonediting applications.

TL;DR: An adaption of a previously developed CRISPR system in Candida parapsilosis that uses an autonomously replicating plasmid that shows that editing can easily be carried out in multiple C. tropicalis isolates and can be used to introduce molecular barcodes and to reintroduce wild-type sequences into edited strains.